Skip to content

Envoy Medical COCH Issuance Of Placement Agent Warrants

Issuance Of Placement Agent Warrants at other companies

XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$239.25K
CNT
Canton Strategic Holdings, Inc. Common StockCNTN
$42.25K+9.1%
Agrify Corporation logo
Agrify CorporationRYM
$6.5K
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$0
TuHURA Biosciences, Inc. logo
TuHURA Biosciences, Inc.HURA
$110.89K
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$0

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept coch:IssuanceOfPlacementAgentWarrants.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's issuance of placement agent warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's issuance of placement agent warrants?
Envoy Medical (COCH) reported issuance of placement agent warrants of $678K in Q1 2026.
How has Envoy Medical's issuance of placement agent warrants changed year-over-year?
Envoy Medical's issuance of placement agent warrants increased by 593.6% year-over-year, from $97.75K to $678K.
What does issuance of placement agent warrants mean?
Captures the fair value of equity warrants granted to placement agents as compensation for facilitating capital raises. This represents a form of non-cash financing cost that impacts the total cost of equity issuance.